BEIJING: China has issued a set of ethical rules on human genome editing, reiterating a strict ban on altering germ cells and embryos and clarifying standard ethical practices for gene editing research.
The guideline was formulated by the medical ethics subcommittee of the National Science and Technology Ethics Committee and released on the website of the Ministry of Science and Technology on Wednesday.
“At present, any clinical research involving germline genome editing is irresponsible and not permitted,” it said.
“Only when there is a full understanding and considering of benefits, risks and alternative options, when the safety and efficacy issues are addressed, broad consensus achieved and rigorous assessment completed can the possibility of carrying out such research under tight supervision be evaluated.”
The document highlights that using edited germ cells, fertilized eggs or human embryos for pregnancy or reproduction is strictly prohibited.
Regarding clinical research involving genome editing of somatic cells — which are cells in the body other than sperm and egg cells — it said that such research should be aimed at preventing or treating diseases and should be carried out after animal tests or preclinical, in vitro experiments have offered basic evidence of safety and efficacy. –The Daily Mail-China Daily news exchange item
